Skip to Navigation
Skip to Content

Support PSR!

Make a difference in the challenge to confront global warming and prevent nuclear war and the development and use of nuclear weapons.

Donate Now »

Take Action

Tell the EPA you want strong standards in 2016 for methane leaks from existing natural gas and oil wells.

PSR Helps Reduce HEU Proliferation Risk

Posted by Peter Wilk, MD on October 30, 2009

Back in June, PSR joined an appeal from a broad and unprecedented coalition of nuclear medical and nonproliferation groups urging Congress to fund domestic production of medical isotopes without bomb-grade uranium, to ensure supply of the isotopes while reducing risks of nuclear terrorism. 

On October 29th, President Obama approved $20 million to jump-start U.S. domestic production of medical isotopes without the use of bomb-grade, highly enriched uranium (HEU), by signing into law the 2010 Energy and Water Appropriations bill.

The president and Congress acted in response to a sustained coalition effort led by Alan J. Kuperman, PhD,director of the Nuclear Proliferation Prevention Program at the University of Texas at Austin. "This is exactly what we were hoping for -- a kick-start of domestic production without the use of bomb-grade uranium, to both restore a reliable supply of isotopes and reduce risks of nuclear terrorism,” stated Dr. Kuperman.

Molybdenum-99 is an isotope whose decay product, Technecium-99m, is used in the majority of 20-million medical diagnostic procedures annually in the United States.  For over two decades, the United States has imported its entire supply of this vital isotope from producers in Canada and Europe, who utilize bomb-grade uranium in the manufacturing process.  Recent production interruptions at aging facilities in Canada and the Netherlands have cut U.S. supplies and increased prices, triggering a partial reversion to less effective and more invasive medical procedures.
The appropriations bill conference report states: "From within available resources, $20,000,000 shall be provided to accelerate the conversion of research reactors to support the domestic production of molybdenum-99."

Complementing this year's appropriation, the House Energy and Commerce Committee on October 21 approved the American Medical Isotopes Production Act of 2009, which authorizes $163 million over five years to "support projects for the production in the United States, without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses."  The bill also phases out U.S. exports of bomb-grade uranium within seven years, to persuade foreign producers likewise to eliminate this risky material from their manufacturing processes. 


Leave your comment

Enter this word: Change

Action Alerts

More action alertsĀ»


  • Video: Can We Prevent Nuclear War?

    The danger of nuclear war is real. PSR's Dr. Ira Helfand spoke at TEDx Vail on the threat to human survival posed by nuclear war and what we can do about it: we can all take action to end nuclear weapons in all forms. Read more »

  • Dr. Ira Helfand Speaks at the UN

    Dr. Ira Helfand spoke before the Untied Nations General Assembly on September 10, 2015 as part of a panel addressing the pursuit of a nuclear weapons free world. Read more »

  • Video: We Have an Iran Deal! Now What?

    Watch PSR Security Program's latest webinar to understand the details of the Iran Deal and what you can do to keep the deal safe from Congress. Featuring speaker Kelsey Davenport, Arms Control Association. Read more »

In the Spotlight